Dr. Herbst on the International Lung Cancer Congress

Roy S. Herbst, MD, PhD
Published: Tuesday, Aug 09, 2011

Roy S. Herbst, MD, PhD, Chief of Medical Oncology, Yale Comprehensive Cancer Center, describes the 12th International Lung Cancer Congress that he co-leads with David Gandara, MD. He explains this years congress is unique from previous years because of its excellent faculty and timely breakout sessions. The breakout sessions were designed in the past 2 months in order to be up-to-date with recent events.
Roy S. Herbst, MD, PhD, Chief of Medical Oncology, Yale Comprehensive Cancer Center, describes the 12th International Lung Cancer Congress that he co-leads with David Gandara, MD. He explains this years congress is unique from previous years because of its excellent faculty and timely breakout sessions. The breakout sessions were designed in the past 2 months in order to be up-to-date with recent events.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine TumorsMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x